Ok-To The Moon - Tiger Brokers Online Investing Community - To The Moon

1
1
Favorite

SMLim
2022-10-19

Ok

Akouos Stock Soars 85% as Eli Lilly Buys Genetic Therapies Company for $610 Million

The pharmaceutical giant Eli Lilly announced that it will buy the genetic medicine company Akouos fo

Akouos Stock Soars 85% as Eli Lilly Buys Genetic Therapies Company for $610 Million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

1

Report

Comment（1）

Top
Latest

SMLim
·2022-10-19
[Miser]
Reply
Like
Report

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":9983082307,"tweetId":"9983082307","gmtCreate":1666114725109,"gmtModify":1676537708015,"author":{"id":3586259427226842,"idStr":"3586259427226842","authorId":3586259427226842,"authorIdStr":"3586259427226842","name":"SMLim","avatar":"https://static.tigerbbs.com/b84ccf92cfb9ec3d527d12880bb472db","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.05","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":54,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>Ok</p></body></html>","htmlText":"<html><head></head><body><p>Ok</p></body></html>","text":"Ok","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/9983082307","repostId":1136877041,"repostType":4,"repost":{"id":"1136877041","kind":"news","pubTimestamp":1666103219,"share":"https://www.laohu8.com/m/news/1136877041?lang=&edition=full","pubTime":"2022-10-18 22:26","market":"us","language":"en","title":"Akouos Stock Soars 85% as Eli Lilly Buys Genetic Therapies Company for $610 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1136877041","media":"Barron's","summary":"The pharmaceutical giant Eli Lilly announced that it will buy the genetic medicine company Akouos fo","content":"<html><head></head><body><p>The pharmaceutical giant Eli Lilly announced that it will buy the genetic medicine company Akouos focused on hearing improvement, for up to $610 million.</p><p>Shares of Akouos soared 85% in morning trading Tuesday to $13, while Lilly’s stock slipped 0.22%.</p><p><img src=\"https://static.tigerbbs.com/f73c1c1ae1e8f649586c2ccb6e21bb81\" tg-width=\"828\" tg-height=\"846\" referrerpolicy=\"no-referrer\"/><img src=\"https://static.tigerbbs.com/bed33aec19b9b78d25a51676852d47e7\" tg-width=\"830\" tg-height=\"828\" referrerpolicy=\"no-referrer\"/></p><p>The merger of these two companies is meant to help them accelerate gene therapies that will help improve hearing for patients, according to a joint news release.</p><p>“We believe that with Lilly’s resources, global reach, and growing capabilities in gene therapy, we can help Akouos fulfill their mission of making healthy hearing available to all,” Andrew Adams, co-director at the Lilly Institute for Genetic Medicine, said in the news release.</p><p>Lilly (ticker: LLY) will commence a tender offer to acquire all outstanding shares of  Akouos (AKUS) for a purchase price of $12.50 per share in cash, which equals around $487 million. The size of the deal could grow to about $610 million, or bump it up an extra $3-a-share to $15.50 if certain goals are hit linked to drug trials.</p><p>Such contingent value rights will be paid based on the treatments for hearing loss hitting certain milestones throughout the next few years and gaining regulatory approval by the Food and Drug Administration by or before Dec. 31 of 2026.</p><p>The transaction is expected to close in the fourth quarter of 2022.</p></body></html>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Akouos Stock Soars 85% as Eli Lilly Buys Genetic Therapies Company for $610 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAkouos Stock Soars 85% as Eli Lilly Buys Genetic Therapies Company for $610 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-18 22:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/articles/akouos-stock-soars-eli-lilly-deal-51666098346?mod=mw_latestnews><strong>Barron's</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The pharmaceutical giant Eli Lilly announced that it will buy the genetic medicine company Akouos focused on hearing improvement, for up to $610 million.Shares of Akouos soared 85% in morning trading ...</p>\n\n<a href=\"https://www.marketwatch.com/articles/akouos-stock-soars-eli-lilly-deal-51666098346?mod=mw_latestnews\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AKUS":"Akouos, Inc.","LLY":"礼来"},"source_url":"https://www.marketwatch.com/articles/akouos-stock-soars-eli-lilly-deal-51666098346?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136877041","content_text":"The pharmaceutical giant Eli Lilly announced that it will buy the genetic medicine company Akouos focused on hearing improvement, for up to $610 million.Shares of Akouos soared 85% in morning trading Tuesday to $13, while Lilly’s stock slipped 0.22%.The merger of these two companies is meant to help them accelerate gene therapies that will help improve hearing for patients, according to a joint news release.“We believe that with Lilly’s resources, global reach, and growing capabilities in gene therapy, we can help Akouos fulfill their mission of making healthy hearing available to all,” Andrew Adams, co-director at the Lilly Institute for Genetic Medicine, said in the news release.Lilly (ticker: LLY) will commence a tender offer to acquire all outstanding shares of  Akouos (AKUS) for a purchase price of $12.50 per share in cash, which equals around $487 million. The size of the deal could grow to about $610 million, or bump it up an extra $3-a-share to $15.50 if certain goals are hit linked to drug trials.Such contingent value rights will be paid based on the treatments for hearing loss hitting certain milestones throughout the next few years and gaining regulatory approval by the Food and Drug Administration by or before Dec. 31 of 2026.The transaction is expected to close in the fourth quarter of 2022.","news_type":1},"isVote":1,"tweetType":1,"viewCount":530,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":104401944,"commentId":"104401944","gmtCreate":1666114740785,"gmtModify":1666114743966,"authorId":3586259427226842,"author":{"id":3586259427226842,"idStr":"3586259427226842","authorId":3586259427226842,"name":"SMLim","avatar":"https://static.tigerbbs.com/b84ccf92cfb9ec3d527d12880bb472db","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.05","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9983082307,"objectIdStr":"9983082307","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"<span class=\"s1\">[Miser]</span>","text":"<span class=\"s1\">[Miser]</span>","html":"<span class=\"s1\">[Miser]</span>","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0}],"hasMoreComment":true,"orderType":2}